الفهرس | Only 14 pages are availabe for public view |
Abstract Breast cancer is most common cause of cancer deaths among women worldwide. Despite the improvement in the detection of breast cancer with the widespread application of mammography and ultrasound, some breast lesions still remain difficult to diagnose and characterize, especially in dense fibroglandular breasts and in differentiating post-operative changes from recurrent masses. Sonomammographically diagnosed BIRADS III and BIRADS IV lesions are considered indeterminate breast lesions and imaging dilemmas. This raised the need for other imaging modalities that would surpass the sensitivity and specificity of mammography alone or combined mammography and ultrasonography in the screening and ultimately final diagnosis of malignancy among patients presenting with such questionable lesions, hence was the need for breast MR imaging. The sensitivity of breast MRI for the detection of cancer is the greatest of all imaging techniques especially when the findings of conventional imaging are inconclusive. MRI can be used as a problem-solving modality, it is also better at identifying the true extent of cancer and help in cancer staging when multifocal disease or ductal carcinoma in situ is present. However its repConsequently, there has been considerable interest in the development of adjunct MR imaging methods to improve the specificity of conventional MR imaging. Both dynamic contrast-enhanced breast MR imaging and diffusion-weighted breast MR imaging are being investigated for their potential to improve breast disease diagnosis. It is desirable that a diagnostic test in the breast should either rule in or rule out malignancy. The application of additional dynamic and DWI to MRI protocols helps us to achieve such outcome. In this study we attempted to investigate the validity of Dynamic post-contrast sequences, DWI and ADC measurements in differentiating benign and malignant breast lesions among the study group and further correlation of the study results with histopathological data following biopsy and/or surgical excision of those lesions. The study included 30 patients. All patients underwent conventional MR imaging, contrast enhanced-MRI, DWI and ADC values measurements with documentation of findings. We found that DWI improves the diagnostic accuracy of the DCE-MRI of the breast. It is a better method for detecting breast lesions than either T1- or T2-weighted imaging, however, it is better to be performed in conjunction with contrast enhanced MRI, which becomes of great help in differentiating between post therapeutic changes from recurrentorted specificity is breast cancers. It also can reduce the number of false-positive results and associated unnecessary biopsiesvariable. |